Stock Comparison

JNJ vs OSCR

Johnson & Johnson vs Oscar Health Inc

The Verdict

OSCR takes this one.

JNJ

Johnson & Johnson

1.0

out of 10

Distressed

Winner

OSCR

Oscar Health Inc

8.5

out of 10

Hidden Gem

Head-to-Head

$557.1B

Market Cap

$8.4B

26.5

P/E Ratio

49.6

21.8%

Profit Margin

-0.3%

26.3%

Return on Equity

-3.3%

0.6

Debt-to-Equity

0.4

Conservative

Overall Risk

Aggressive

1.0

DVR Score

8.5

The Deep Dive

JNJ1.0/10

Johnson & Johnson (JNJ) continues to demonstrate robust financial performance, with Q1 2026 results exceeding consensus on both revenue and adjusted EPS, reflecting nearly 10% YoY revenue growth. Its diversified healthcare portfolio provides significant market leadership and a wide economic moat, indicating stability and consistent profitability. However, its massive market capitalization of $555....

Full JNJ Analysis

OSCR8.5/10

Oscar Health's Q1 2026 results represent a material positive shift, showcasing exceptional profitability with a net income of ~$679M and a 15.2% operating margin on $4.65B revenue, exceeding previous analysis's general mention of beating consensus. This strongly validates its operational turnaround and path to market leadership in insurtech. The reaffirmation of robust full-year 2026 revenue guida...

Full OSCR Analysis

Want More Comparisons?

Run any stock through our deep value analyzer.

Analyze Any Stock →

Not Financial Advice

This comparison is for educational purposes only. We are not financial advisors. Always do your own research and consult a qualified advisor before investing.